We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Plant Health Care Plc | LSE:PHC | London | Ordinary Share | GB00B01JC540 | ORD 1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 3.86 | 122 | 08:10:26 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 3.60 | 4.10 | ||||
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pesticides, Agric Chems, Nec | USD 11.77M | USD -9.48M | USD -0.0278 | -1.39 | 13.18M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 11:30:17 | O | 122 | 3.9563 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 22/4/2024 | 15:29 | ALNC |  Plant Health Care hails Harpinab approval in Belgium |
| 22/4/2024 | 07:00 | UK RNS | Plant Health Care PLC Approval of Harpinαβ in Belgium |
| 16/4/2024 | 20:34 | ALNC | EARNINGS AND TRADING: AssetCo deputy retiring, Chapel Down ups revenue |
| 16/4/2024 | 07:00 | UK RNS | Plant Health Care PLC Plant Health Care--China Distribution with AMVAC |
| 04/4/2024 | 12:39 | ALNC | Plant Health Care's nematode control product approved in Mexico |
| 04/4/2024 | 07:00 | UK RNS | Plant Health Care PLC Approval of PHC68949 in Mexico |
| 04/3/2024 | 13:55 | UK RNS | Plant Health Care PLC Holding(s) in Company |
| 23/2/2024 | 08:59 | ALNC | TRADING UPDATES: Plant Health eyes Mexico Saori launch; NARF wins deal |
| 22/2/2024 | 07:00 | UK RNS | Plant Health Care PLC Mexico approves SAORI |
| 24/1/2024 | 16:27 | UKREG | Plant Health Care PLC Holding(s) in Company |
Plant Health Care (PHC) Share Charts1 Year Plant Health Care Chart |
|
1 Month Plant Health Care Chart |
Intraday Plant Health Care Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 22/4/2024 | 12:51 | Plant Health Care; Using novel biological products in global markets | 830 |
| 16/7/2018 | 09:03 | PHC - 24p - MASSIVE BOWL ON CHART TO 120p | 101 |
| 10/8/2016 | 11:25 | Throw away the artificial Fertilizer with Plant Health Care | 408 |
| 15/3/2011 | 17:27 | Plant Health Care | 20 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 10:30:17 | 3.96 | 122 | 4.83 | O |
| 2024-04-22 12:14:31 | 3.99 | 3,000 | 119.58 | O |
| Top Posts |
|---|
Posted at 23/4/2024 09:20 by Plant Health Care Daily Update Plant Health Care Plc is listed in the Pesticides, Agric Chems, Nec sector of the London Stock Exchange with ticker PHC. The last closing price for Plant Health Care was 3.86p.Plant Health Care currently has 341,532,952 shares in issue. The market capitalisation of Plant Health Care is £13,183,172. Plant Health Care has a price to earnings ratio (PE ratio) of -1.39. This morning PHC shares opened at - |
Posted at 20/4/2024 17:00 by cerrito I see that last year we got the results onApril 12th and the year before on April 28th. They give us s notice of results RNS and a good chance we will get thst this week.Incidentally I went on the news section of the AMVAC website to see if they posted news of the PHC China tie up.They had not and given the size of AMVAC that it no way surprised me. |
Posted at 20/4/2024 16:50 by cerrito Good question slicethepie as to when they get taken out.Industry players appear to have a different view of PHC prospects than Cavendish with their 42p target price and I am a bit uncomfortable that in all these months that the share price has been in the 3's that no-one has come on big to replace Mr Griffiths. My question mark and indeed concern is how Ispraie see this. I have no insight into their level of patience/requirement for liquidity nor indeed of their investors. The mind boggles as to what would happen to he share price if they followed-or tried to follow-Mr Griffiths to the exit door. |
Posted at 17/4/2024 07:45 by robsy2 I am trying to get my head around the investment case for this company so have PHC on my watchlist, am readingthe posts and research with interest.Lots of bumps in the road but the company seems to be making good progress and is about to become profitable yet the share price is at an all time low. With new distribution deals and approvals being announced, could be things are on the move? |
Posted at 16/4/2024 08:24 by cerrito From the way it is worded my reading is that no regulatory approvals are required in China but would have been good to get clarity on this.Confused by the reference to novel as it is good old harpin and my reading is that it is because it is being incorporated into an existing AMVAC product line. I may be wrong but if true could be v exciting. American Vanguard is listed and describes itself as an agriculture and speciality chemical company. Sales and profits declined in 2023 over 2022 and indeed eps declined from 92us cents to 26.It does have a green division.They attributed fall in 2023 sales to our old friend destocking(though said this reversed in q4 calendar 2023), oversupply of Chinese generic products(not a PHC issue) and supply chain problems. |
Posted at 16/4/2024 07:43 by pretax2 There’re no figures on this RNS, but China distribution commencing this year is a huge opportunity for PHC. I look forward to hearing more; also nice to know PHC are alive and kicking. |
Posted at 07/4/2024 18:44 by pretax2 Hi CerritoNot sure how to interpret this (+ve or -ve) as far as PHC is concerned. 1/ "Indigo expanded into too many product areas": PHC have not - they've stuck with Harpin derived peptides. 2/ "Industry of slow adapters": Accepted; but environmental (and supermarket) policy is forcing growers to embrace sustainable growing techniques or lose market share. 3/ "Many of these agtech companies are not ‘tech’ companies, they are simply ‘tech enabled’". ['Tech enabled'?] Harpin is a scientific discovery which has been adapted and enhanced by PHC at its Seattle laboritory. All of the IP belongs to PHC. Somewhat paradoxically, Covid was 'initially' a good thing for PHC (distributors over-stocked), but now a bad thing with the current destocking. This out to be ending around about now so we can get back on the growth path. Time for an update. |
Posted at 22/11/2023 23:37 by cerrito I woke up Wednesday very long and very wrong on PHC and went to bed even longer and wronger. The key that made me comfortable buying more is that they have no immediate need for funds-their equity raise in June was in retrospect a v good move.I note Cenkos/Cavendish remain comfortable having a positive ebitda next year(good as no interest or tax to pay) , as a result of expense reduction, though I have never had the feeling they have had much fat to cut. We have no info on the profitability of the different geographies. Given their business mix, Mexico profitability per sales is I assume the worst and I go on the basis that NA is more profitable than La as LA more of a start up.Remember NA sales in 2022 were usd 4.8m put of usd11.8m. Cavendish in their note referred to the FMC investor day on November 16 when FMC commented on destocking trends. Specifi Note that FMC talking about the effects of destocking continuing into H1 24. There is however the question that on September 25 in the interims PHC wrote quote With lower inventories and strong customer on-ground sales, we are expecting a strong second half of 2023 with material revenue growth anticipated.unquote. Given today's heavy trading activities with 33m shares traded we await with interest any TR1's.I have to say that in some way with the current msrcap(even if sterling is currently stronger against the dollar than it has been for much of the last year), I would be worried if we did not get a takeover bid as it would suggest that PHC is not undervalued. |
Posted at 22/11/2023 09:10 by pretax2 Covid is valid excuse. Distributors bought loads of product during Covid due to transportation issues. Whist our products are selling in the US, distributors have stocks to meet demand currently.It’s a bump in the road and will shake a few people out, but I’m struggling to see how PHC are to blame for broader economic and regulatory issues. Delays to our progress are regrettable and the share price fall is inevitable. But there’s no fatal flaw in the business model, it’ll just take a longer to play out. My shares go back into the coffee can. |
Posted at 26/4/2023 12:33 by pretax2 If you don’t mind me giving my own 2.5p worth.Both CR and JT have indicated that the share price should be higher. I asked CR why it was stagnating and he suggested that the company seemed to be viewed as a “show me” company. In other words show me that it works, show me that it sells, show me that you’re profitable. Up until last year I might have thought the same but things have fundamentally changed. PHC now has a suite of products; the products work brilliantly; revenue is growing towards profitability. But the big thing for me is climate change, energy change (biofuels), and a biblical food crisis. PHC have an answer for this - so the timing is right too. I guess all great companies start small and investors end up regretting they didn’t buy the shares way back “then” when the share price was peanuts. Well for PHC, this is the ‘peanuts’ 1.Profitability (especially if earlier than expected). 2. Takeover talk. PHC has destribution deals with a number of monster companies. There are also some interesting connections with Syngenta. 3/ Premise: The need for consolidation in the sector is well known and it’s starting to happen. Second, PHC is an American company keen to engage American investors. If you’ll forgive my fight of fancy, how about a reverse takeover of an American ag-tech company? If that happened hold onto your eyebrows, PHC shares would supernova. 4/ No reason at all. Many companies breakout from their doldrums for no apparent reason. There’s just a move to a more realistic value that gets bought into by traders. 5/ Press article. To me PHC has a really exciting story. The right article in the right journal at the right time and bingo. |
Posted at 19/1/2022 17:51 by cerrito Arden’s note on Research Tree a good summary pf the WE IMC meeting. It was good to hear that 279 will have a shelf life of 5 years; interested in the WE comment that these days a new product launch needs greater investment in time and effort than before and also that if a new product has not caught on after three years it never will.Good that Arden’s forecast has $4m of cash at the end of 22 with no equity raises forecast for 22. The PHC share price is suffering the same fate as my pre profit clean tech stocks such as CWR and ITM. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
